USD 0.59
(-6.73%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 37.68 Million USD | 175.16% |
2022 | 13.69 Million USD | 82.88% |
2021 | 7.48 Million USD | -36.06% |
2020 | 11.71 Million USD | 243.26% |
2019 | 3.41 Million USD | 0.47% |
2018 | 3.39 Million USD | -73.96% |
2017 | 13.04 Million USD | 0.07% |
2016 | 13.03 Million USD | 24.19% |
2015 | 10.49 Million USD | 24.1% |
2014 | 8.45 Million USD | -16.65% |
2013 | 10.14 Million USD | 5.82% |
2012 | 9.58 Million USD | 77.7% |
2011 | 5.39 Million USD | 243.41% |
2010 | 1.57 Million USD | -38.75% |
2009 | 2.56 Million USD | -9.97% |
2008 | 2.84 Million USD | -12.69% |
2007 | 3.26 Million USD | -27.22% |
2006 | 4.48 Million USD | 418.41% |
2005 | 864.78 Thousand USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 39.08 Million USD | 1.24% |
2024 Q1 | 38.6 Million USD | 2.43% |
2023 Q4 | 37.68 Million USD | -11.76% |
2023 Q2 | 18.81 Million USD | 15.97% |
2023 FY | 37.68 Million USD | 175.16% |
2023 Q3 | 42.71 Million USD | 126.98% |
2023 Q1 | 16.22 Million USD | 18.47% |
2022 Q2 | 12.25 Million USD | 29.31% |
2022 Q4 | 13.69 Million USD | -4.01% |
2022 FY | 13.69 Million USD | 82.88% |
2022 Q3 | 14.26 Million USD | 16.39% |
2022 Q1 | 9.48 Million USD | 26.59% |
2021 Q3 | 5.48 Million USD | -17.17% |
2021 FY | 7.48 Million USD | -36.06% |
2021 Q4 | 7.48 Million USD | 36.64% |
2021 Q1 | 8.93 Million USD | -23.75% |
2021 Q2 | 6.61 Million USD | -25.9% |
2020 Q4 | 11.71 Million USD | -13.04% |
2020 Q1 | 518 Thousand USD | -84.82% |
2020 Q2 | 25.39 Million USD | 4803.09% |
2020 Q3 | 13.46 Million USD | -46.97% |
2020 FY | 11.71 Million USD | 243.26% |
2019 Q1 | 3.07 Million USD | -9.39% |
2019 Q2 | 3 Million USD | -2.34% |
2019 Q4 | 3.41 Million USD | 2.96% |
2019 Q3 | 3.31 Million USD | 10.28% |
2019 FY | 3.41 Million USD | 0.47% |
2018 Q1 | 5.36 Million USD | -58.84% |
2018 FY | 3.39 Million USD | -73.96% |
2018 Q4 | 3.39 Million USD | -20.19% |
2018 Q3 | 4.25 Million USD | -14.51% |
2018 Q2 | 4.97 Million USD | -7.28% |
2017 Q2 | 10.43 Million USD | -12.76% |
2017 Q4 | 13.04 Million USD | 25.22% |
2017 FY | 13.04 Million USD | 0.07% |
2017 Q1 | 11.95 Million USD | -8.24% |
2017 Q3 | 10.41 Million USD | -0.17% |
2016 Q4 | 13.03 Million USD | 15.77% |
2016 Q3 | 11.25 Million USD | 7.88% |
2016 FY | 13.03 Million USD | 24.19% |
2016 Q1 | 10.85 Million USD | 3.43% |
2016 Q2 | 10.43 Million USD | -3.85% |
2015 Q4 | 10.49 Million USD | -7.57% |
2015 Q3 | 11.35 Million USD | 9.43% |
2015 Q2 | 10.37 Million USD | 60.74% |
2015 Q1 | 6.45 Million USD | -23.66% |
2015 FY | 10.49 Million USD | 24.1% |
2014 Q1 | 8.49 Million USD | -16.27% |
2014 Q2 | 7.78 Million USD | -8.38% |
2014 Q4 | 8.45 Million USD | 15.96% |
2014 FY | 8.45 Million USD | -16.65% |
2014 Q3 | 7.29 Million USD | -6.3% |
2013 Q1 | 8.74 Million USD | -8.8% |
2013 Q2 | 7.22 Million USD | -17.35% |
2013 Q3 | 7.82 Million USD | 8.25% |
2013 Q4 | 10.14 Million USD | 29.7% |
2013 FY | 10.14 Million USD | 5.82% |
2012 Q2 | 8.02 Million USD | 22.51% |
2012 FY | 9.58 Million USD | 77.7% |
2012 Q1 | 6.55 Million USD | 21.48% |
2012 Q4 | 9.58 Million USD | 22.99% |
2012 Q3 | 7.79 Million USD | -2.91% |
2011 Q2 | 5.01 Million USD | 44.7% |
2011 FY | 5.39 Million USD | 243.41% |
2011 Q3 | 3.29 Million USD | -34.34% |
2011 Q1 | 3.46 Million USD | 120.56% |
2011 Q4 | 5.39 Million USD | 63.88% |
2010 FY | 1.57 Million USD | -38.75% |
2010 Q4 | 1.57 Million USD | 63.31% |
2010 Q2 | 1.47 Million USD | -46.52% |
2010 Q3 | 962 Thousand USD | -34.82% |
2010 Q1 | 2.76 Million USD | 7.6% |
2009 Q4 | 2.56 Million USD | 19.08% |
2009 Q1 | 2.9 Million USD | 1.86% |
2009 Q3 | 2.15 Million USD | -8.96% |
2009 Q2 | 2.36 Million USD | -18.47% |
2009 FY | 2.56 Million USD | -9.97% |
2008 Q4 | 2.84 Million USD | -5.29% |
2008 Q1 | 2.2 Million USD | -32.39% |
2008 FY | 2.84 Million USD | -12.69% |
2008 Q2 | 3.54 Million USD | 60.79% |
2008 Q3 | 3 Million USD | -15.2% |
2007 Q4 | 3.26 Million USD | -15.27% |
2007 FY | 3.26 Million USD | -27.22% |
2007 Q2 | 4.39 Million USD | 0.05% |
2007 Q3 | 3.85 Million USD | -12.34% |
2007 Q1 | 4.39 Million USD | -2.06% |
2006 Q4 | 4.48 Million USD | 88.3% |
2006 Q3 | 2.38 Million USD | 94.97% |
2006 FY | 4.48 Million USD | 418.41% |
2006 Q1 | 714.17 Thousand USD | -17.42% |
2006 Q2 | 1.22 Million USD | 70.98% |
2005 Q4 | 864.78 Thousand USD | 39.04% |
2005 Q2 | 105 Thousand USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | 864.78 Thousand USD | 0.0% |
2005 Q3 | 621.98 Thousand USD | 492.37% |
2004 FY | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -686.92% |
Safety Shot Inc | 1.86 Million USD | -1915.675% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 75.223% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 66.108% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -456.744% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -16.559% |
Dynavax Technologies Corporation | 53.29 Million USD | 29.281% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 42.572% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -223.568% |
Pacira BioSciences, Inc. | 104.35 Million USD | 63.886% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -557.151% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -557.151% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -4553.989% |
Journey Medical Corporation | 10.2 Million USD | -269.253% |
Alpha Teknova, Inc. | 11.59 Million USD | -225.047% |
Procaps Group, S.A. | 96.83 Million USD | 61.081% |
Theratechnologies Inc. | 6.06 Million USD | -521.266% |
Harrow Health, Inc. | 10.86 Million USD | -246.793% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1286.024% |
Biofrontera Inc. | 10.9 Million USD | -245.49% |
DURECT Corporation | 2.21 Million USD | -1598.333% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 51.315% |
Cronos Group Inc. | 30.33 Million USD | -24.216% |
OptiNose, Inc. | 8.05 Million USD | -368.033% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -3768599900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -561.27% |
Organogenesis Holdings Inc. | 28.25 Million USD | -33.388% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -1307.711% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -717.597% |
Radius Health, Inc. | 278.64 Million USD | 86.475% |
Universe Pharmaceuticals INC | 3.34 Million USD | -1027.221% |
ProPhase Labs, Inc. | 3.84 Million USD | -881.151% |
Phibro Animal Health Corporation | 265.91 Million USD | 85.828% |
Procaps Group S.A. | 96.83 Million USD | 61.081% |
Alvotech | 74.43 Million USD | 49.369% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 98.914% |
Rockwell Medical, Inc. | 5.87 Million USD | -541.901% |
Aytu BioPharma, Inc. | 12.63 Million USD | -198.314% |
SIGA Technologies, Inc. | 64.21 Million USD | 41.316% |
Tilray Brands, Inc. | 252.08 Million USD | 85.05% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 5.736% |
Shineco, Inc. | 1.58 Million USD | -2272.389% |
PetIQ, Inc. | 159.3 Million USD | 76.344% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 24767.164% |
Incannex Healthcare Limited | -10.01 Million USD | 476.296% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 1.603% |
Alimera Sciences, Inc. | 1.87 Million USD | -1905.641% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -2240.177% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -740.642% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -14716.475% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -263.064% |
Hempacco Co., Inc. | 2.54 Million USD | -1382.167% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 49.369% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 21.149% |
Lantheus Holdings, Inc. | 64.02 Million USD | 41.142% |
Currenc Group, Inc. | 732.91 Thousand USD | -5041.961% |
Kamada Ltd. | 87.74 Million USD | 57.051% |
Indivior PLC | 141.79 Million USD | 73.423% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -7721.268% |
Flora Growth Corp. | 8.5 Million USD | -342.948% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -14716.475% |
Evolus, Inc. | 10.99 Million USD | -242.662% |
HUTCHMED (China) Limited | 50.25 Million USD | 25.015% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 64.391% |
Akanda Corp. | 1.28 Million USD | -2828.446% |